Spike Protein from mRNA COVID Shots Detected in Placenta and Fetal Cells
A new peer-reviewed study has found spike protein and vaccine-derived mRNA in human placental tissue and fetal immune cells, including in mothers who were vaccinated before pregnancy and had no documented SARS-CoV-2 infection. The study, published Mar. 5, 2026 in PLOS One, analyzed 106 placentas from women who delivered between 2020 and 2022 and used […]
Upcoming ACIP Meeting to Focus on COVID-19 Shot Injuries
The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) are scheduled to meet on Mar. 18-19, 2026 to discuss the injuries to people who received COVID-19 shots and the matter of safety monitoring related to the shots, particularly with regard to the development of myocarditis (inflammation of the heart […]
Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission
The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]
Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]
FDA Greenlights Review of Moderna’s mRNA Flu Shot After Application Amended
On Feb. 18, 2026, the U.S. Food and Drug Administration (FDA) agreed to review Moderna’s application for its mRNA influenza shot, known as mRNA-1010, after the company amended its submission to address regulatory concerns. The agency accepted the updated biologics license application and set a target action date of Aug. 5, 2026, allowing the shot […]
Study Finds More MMR/MMRV Death Reports Than Deaths from Measles
A new study has found a significant number of deaths among infants and toddlers within days of receiving MMR/MMRV combination vaccines, particularly after the routine first-dose at 12 to 15 months, with reported deaths exceeding documented measles fatalities in the United States.1 The preprint, which examined Vaccine Adverse Event Reporting System (VAERS) death reports, identified […]